BioSpace News Archive

The demand in the global clinical decision support system market has been on the rise in recent years.

A freshly compiled business intelligence study by Transparency Market Research has detected that the shares in the global market for vial adaptors for reconstitution drugs are considerably consolidated within a handful of prominent players.

Personalized medications have gained traction in recent years. This popularity is the key factor that is driving the growth of global compounding pharmacies.

ChromaDex R&D program continues to pioneer NAD+ and Niagen® research and inks over 200 external research collaborations

Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune disease, announced that the first patient has been dosed in a Phase 1 study of NX-13, the Company’s novel, orally administered therapeutic candidate for the treatment of inflammatory bowel disease.

Multi-center, Randomized, Double-Blind, Placebo-Controlled Clinical study targeting the prevention of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury (AKI) in Patients Infected with SARS-CoV-2 (COVID-19)

New alliance will use insights from translational and clinical studies to better identify targets, combinations and potential new indications for current medicines

STAAR Surgical Company announced that to support the health and well-being of its shareholders, employees, directors, and communities due to the public health threat of the COVID-19 pandemic the Company’s upcoming 2020 Annual Meeting of Shareholders will be held in a virtual-only format.

QINLOCK is the First Approved Tyrosine Kinase Inhibitor Designed Specifically for GIST Regardless of Patients’ Mutational Status

The pandemic has highlighted the importance of supporting scientific research in order to allow investigators to find real solutions to deal with public health issues such as COVID-19 or cancer.